IBDEI0Y6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16044,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,16044,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,16045,0)
 ;;=D06.9^^61^717^2
 ;;^UTILITY(U,$J,358.3,16045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16045,1,3,0)
 ;;=3^Carcinoma in Situ,Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,16045,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,16045,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,16046,0)
 ;;=D06.0^^61^717^3
 ;;^UTILITY(U,$J,358.3,16046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16046,1,3,0)
 ;;=3^Carcinoma in Situ,Endocervix
 ;;^UTILITY(U,$J,358.3,16046,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,16046,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,16047,0)
 ;;=D06.1^^61^717^4
 ;;^UTILITY(U,$J,358.3,16047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16047,1,3,0)
 ;;=3^Carcinoma in Situ,Exocervix
 ;;^UTILITY(U,$J,358.3,16047,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,16047,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,16048,0)
 ;;=D06.7^^61^717^1
 ;;^UTILITY(U,$J,358.3,16048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16048,1,3,0)
 ;;=3^Carcinoma in Situ,Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,16048,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,16048,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,16049,0)
 ;;=C53.9^^61^717^13
 ;;^UTILITY(U,$J,358.3,16049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16049,1,3,0)
 ;;=3^Malig Neop Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,16049,1,4,0)
 ;;=4^C53.9
 ;;^UTILITY(U,$J,358.3,16049,2)
 ;;=^5001204
 ;;^UTILITY(U,$J,358.3,16050,0)
 ;;=C57.01^^61^717^15
 ;;^UTILITY(U,$J,358.3,16050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16050,1,3,0)
 ;;=3^Malig Neop Fallopian Tube,Right
 ;;^UTILITY(U,$J,358.3,16050,1,4,0)
 ;;=4^C57.01
 ;;^UTILITY(U,$J,358.3,16050,2)
 ;;=^5001216
 ;;^UTILITY(U,$J,358.3,16051,0)
 ;;=C57.02^^61^717^14
 ;;^UTILITY(U,$J,358.3,16051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16051,1,3,0)
 ;;=3^Malig Neop Fallopian Tube,Left
 ;;^UTILITY(U,$J,358.3,16051,1,4,0)
 ;;=4^C57.02
 ;;^UTILITY(U,$J,358.3,16051,2)
 ;;=^5001217
 ;;^UTILITY(U,$J,358.3,16052,0)
 ;;=C56.1^^61^717^17
 ;;^UTILITY(U,$J,358.3,16052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16052,1,3,0)
 ;;=3^Malig Neop Ovary,Right
 ;;^UTILITY(U,$J,358.3,16052,1,4,0)
 ;;=4^C56.1
 ;;^UTILITY(U,$J,358.3,16052,2)
 ;;=^5001212
 ;;^UTILITY(U,$J,358.3,16053,0)
 ;;=C56.2^^61^717^16
 ;;^UTILITY(U,$J,358.3,16053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16053,1,3,0)
 ;;=3^Malig Neop Ovary,Left
 ;;^UTILITY(U,$J,358.3,16053,1,4,0)
 ;;=4^C56.2
 ;;^UTILITY(U,$J,358.3,16053,2)
 ;;=^5001213
 ;;^UTILITY(U,$J,358.3,16054,0)
 ;;=C55.^^61^717^18
 ;;^UTILITY(U,$J,358.3,16054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16054,1,3,0)
 ;;=3^Malig Neop Uterus,Unspec Part
 ;;^UTILITY(U,$J,358.3,16054,1,4,0)
 ;;=4^C55.
 ;;^UTILITY(U,$J,358.3,16054,2)
 ;;=^5001211
 ;;^UTILITY(U,$J,358.3,16055,0)
 ;;=C52.^^61^717^19
 ;;^UTILITY(U,$J,358.3,16055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16055,1,3,0)
 ;;=3^Malig Neop Vagina
 ;;^UTILITY(U,$J,358.3,16055,1,4,0)
 ;;=4^C52.
 ;;^UTILITY(U,$J,358.3,16055,2)
 ;;=^267232
 ;;^UTILITY(U,$J,358.3,16056,0)
 ;;=C51.9^^61^717^20
 ;;^UTILITY(U,$J,358.3,16056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16056,1,3,0)
 ;;=3^Malig Neop Vulva,Unspec
 ;;^UTILITY(U,$J,358.3,16056,1,4,0)
 ;;=4^C51.9
 ;;^UTILITY(U,$J,358.3,16056,2)
 ;;=^5001202
 ;;^UTILITY(U,$J,358.3,16057,0)
 ;;=D66.^^61^718^7
 ;;^UTILITY(U,$J,358.3,16057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16057,1,3,0)
 ;;=3^Hereditary Factor VIII Deficiency
 ;;^UTILITY(U,$J,358.3,16057,1,4,0)
 ;;=4^D66.
 ;;^UTILITY(U,$J,358.3,16057,2)
 ;;=^5002353
